Lung cancer screening is becoming a global standard, but imagine harnessing these routine scans to detect fibrosing lung disease before symptoms arise and before clinical suspicion. At OSIC, we leverage the world’s largest curated ILD database alongside advanced AI and machine learning techniques to uncover early signs of interstitial lung abnormalities in lung cancer screening scans.

This approach has the power to revolutionize respiratory medicine by enabling earlier detection, precise risk stratification, and timely intervention — improving outcomes for patients worldwide. OSIC serves as an impartial bridge linking academia, industry and AI innovators, offering a unique platform to explore diverse approaches and accelerate progress in lung disease diagnosis.

Join us to exchange ideas, debate insights, and be part of a transformative movement! We hope to see you in San Francisco!